UBS Group’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-797
| Closed | -$7.27K | – | 10411 |
|
|
2024
Q1 | $7.27K | Buy |
+797
| New | +$5.01K | ﹤0.01% | 7396 |
|
|
2023
Q1 | – | Hold |
0
| – | -$10 | – | 10807 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 10588 |
|
|
2022
Q3 | – | Sell |
-223
| Closed | -$15.1K | – | 11207 |
|
|
2022
Q2 | $12K | Buy |
223
+91
| +69% | +$6.43K | ﹤0.01% | 7704 |
|
|
2022
Q1 | $17K | Buy |
+132
| New | +$13.6K | ﹤0.01% | 7687 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 10899 |
|
|
2021
Q3 | – | Sell |
-63
| Closed | -$10.6K | – | 10272 |
|
|
2021
Q2 | $13K | Buy |
63
+28
| +80% | +$6.23K | ﹤0.01% | 7818 |
|
|
2021
Q1 | $10K | Buy |
+35
| New | +$11.8K | ﹤0.01% | 7948 |
|
|
2020
Q4 | – | Sell |
-12
| Closed | -$1.82K | – | 8881 |
|
|
2020
Q3 | $2K | Buy |
+12
| New | +$1.77K | ﹤0.01% | 7708 |
|
|
2020
Q2 | – | Sell |
-132
| Closed | -$18K | – | 8470 |
|
|
2020
Q1 | $12K | Buy |
132
+89
| +207% | +$13.8K | ﹤0.01% | 6834 |
|
|
2019
Q4 | $7K | Buy |
+43
| New | +$13.7K | ﹤0.01% | 7475 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 8343 |
|
|
2019
Q2 | – | Sell |
-13
| Closed | -$12.4K | – | 8236 |
|
|
2019
Q1 | $13K | Buy |
13
+9
| +225% | +$9.68K | ﹤0.01% | 6652 |
|
|
2018
Q4 | $3K | Buy |
+4
| New | +$4.88K | ﹤0.01% | 7747 |
|
|
2018
Q3 | – | Sell |
-7
| Closed | -$9.51K | – | 8345 |
|
|
2018
Q2 | $10K | Buy |
7
+4
| +133% | +$6.34K | ﹤0.01% | 7152 |
|
|
2018
Q1 | $6K | Buy |
+3
| New | +$5.08K | ﹤0.01% | 7174 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 7738 |
|
|
2017
Q3 | – | Sell |
-2
| Closed | -$5.62K | – | 7605 |
|
|
2017
Q2 | $9K | Hold |
2
| – | – | ﹤0.01% | 6859 |
|
|
2017
Q1 | $6K | Buy |
2
+1
| +100% | +$3.54K | ﹤0.01% | 6927 |
|
|
2016
Q4 | $3K | Buy |
+1
| New | +$3.84K | ﹤0.01% | 7443 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 7431 |
|
|
2016
Q2 | – | Sell |
-2
| Closed | -$22.6K | – | 7350 |
|
|
2016
Q1 | $33K | Buy |
+2
| New | +$29.6K | ﹤0.01% | 5817 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 7632 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 7740 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 7202 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 7445 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 8736 |
|
UBS Group's YTEN Position: Q2 2024 in Review
UBS Group sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q2 2024, closing a stake of 797 shares — an estimated $7.27K sold.
UBS Group first reported a position in YTEN in Q1 2016 and held it in 16 quarters. The position peaked at $33K in Q1 2016. 0 funds tracked by Wall St. Rank hold YTEN as of Q2 2024.
- UBS Group reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- UBS Group sold 797 Yield10 Bioscience, Inc. Common Stock shares in Q2 2024, an estimated $7.27K.
- UBS Group first reported a position in Yield10 Bioscience, Inc. Common Stock in Q1 2016 and held it in 16 quarters.
- UBS Group's Yield10 Bioscience, Inc. Common Stock position peaked at $33K in Q1 2016.
- 0 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q2 2024.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.